Trials / Completed
CompletedNCT01932281
SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes
SierraSil as an Ergogenic Aid to Performance in Athletes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- Male
- Age
- 19 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes. A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.
Detailed description
This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | SierraSil | SierraSil is a natural, mineral supplement currently used to improve joint health and function. |
| DIETARY_SUPPLEMENT | Placebo | Sugar pill manufactured to mimic SierraSil 667 mg capsule |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-08-30
- Last updated
- 2015-07-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01932281. Inclusion in this directory is not an endorsement.